Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials

Relative risk reduction and absolute risk reduction measures in the evaluation of clinical trial data are poorly understood by health professionals and the public. The absence of reported absolute risk reduction in COVID-19 vaccine clinical trials can lead to outcome reporting bias that affects the...

Descripción completa

Detalles Bibliográficos
Autor principal: Brown, Ronald B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996517/
https://www.ncbi.nlm.nih.gov/pubmed/33652582
http://dx.doi.org/10.3390/medicina57030199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996517/
https://www.ncbi.nlm.nih.gov/pubmed/33652582
http://dx.doi.org/10.3390/medicina57030199

Ejemplares similares